Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
|
SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
|
SCHEDULE 13G
|
|
(Rule 13d-102)
|
|
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
|
|
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
|
|
PURSUANT TO RULE 13d-2(b)
|
|
(Amendment No. 2)1
|
|
PhaseBio Pharmaceuticals, Inc.
|
|
(Name of Issuer)
|
|
Common Stock, $0.001 par value
|
|
(Title of Class of Securities)
|
|
717224109
|
|
(CUSIP Number)
|
|
December 31, 2021
|
|
(Date of Event Which Requires Filing of this Statement)
|
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
1 The remainder of this cover page shall be filled
out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act.
1
CUSIP No. 717224109
|
1.
|
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Johnson & Johnson
EIN: 22-1024240
|
|||
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
|
|||
|
3.
|
SEC USE ONLY
|
|||
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
|
|||
|
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5.
|
SOLE VOTING POWER
-0-
|
||
|
6.
|
SHARED VOTING POWER
1,607,044
|
|||
|
7.
|
SOLE DISPOSITIVE POWER
-0-
|
|||
|
8.
|
SHARED DISPOSITIVE POWER
1,607,044
|
|||
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,607,044
|
|||
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
|
|||
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.3%*
|
|||
|
12.
|
TYPE OF REPORTING PERSON
CO
|
|||
* Based on 48,089,983 shares of Common Stock outstanding as of November 8, 2021, as reported in the Issuer’s Report on Form 10-Q for the period ended September
30, 2021 filed with the Securities and Exchange Commission on November 10, 2021
2
CUSIP No. 717224109
|
1.
|
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Johnson & Johnson Innovation-JJDC, Inc.
EIN: 22-2007137
|
|||
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
|
|||
|
3.
|
SEC USE ONLY
|
|||
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
|
|||
|
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5.
|
SOLE VOTING POWER
-0-
|
||
|
6.
|
SHARED VOTING POWER
1,607,044
|
|||
|
7.
|
SOLE DISPOSITIVE POWER
-0-
|
|||
|
8.
|
SHARED DISPOSITIVE POWER
1,607,044
|
|||
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,607,044
|
|||
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
|
|||
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.3%*
|
|||
|
12.
|
TYPE OF REPORTING PERSON
CO
|
|||
* Based on 48,089,983 shares of Common Stock outstanding as of November 8, 2021, as reported in the Issuer’s Report on Form 10-Q for the period ended September
30, 2021 filed with the Securities and Exchange Commission on November 10, 2021
3
CUSIP No. 717224109
AMENDMENT NO. 2 TO SCHEDULE 13G (FINAL AMENDMENT)
Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission by the Reporting Persons with respect to the Common
Stock of the Issuer on January 22, 2019 and Amendment No. 1 thereto filed on January 17, 2020 (as so amended, the “Schedule 13G”). Terms defined in the Schedule 13G are used herein as so defined.
The following items of the Schedule 13G are amended and restated to read in their entirety as follows:
Item 4. Ownership
The information requested in this item is incorporated herein by reference to the cover pages to this Amendment No. 2 to Schedule 13G.
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that the Reporting Persons have ceased to be the beneficial owners of more than five
percent of the Common Stock, check the following: [X]
4
CUSIP No. 717224109
SIGNATURE
After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true,
complete and correct.
Dated: February 1, 2022
|
JOHNSON & JOHNSON
|
|||
|
By:
|
/s/ Matthew Orlando
|
||
|
Name:
|
Matthew Orlando
|
||
|
Title:
|
Secretary
|
||
|
JOHNSON & JOHNSON INNOVATION-JJDC, INC.
|
|||
|
By:
|
/s/ Sergio Calvo-Regueros
|
||
|
Name:
|
Sergio Calvo-Regueros
|
||
|
Title:
|
Assistant Treasurer
|
||
5